Panel Discussion "Humanome Research, Beginning."

A panel discussion, "Humanome Research, Begins," will be held within the 7th Annual Conference of the Association of Hyperdifferent Fields, sponsored by RIVANES (March 2 and 3, 2018 @ TEPIA Advanced Technology Pavilion).

Advances in medical technology and science and technology have led to a shift from treatment to prevention, and questions begin to be asked about people's health and the state of society.The Post-Health Era."will surely come.

From understanding all the data about people, looking ahead to that time,What is a person?"Humanom Research is the study of the human genome, which pursues the "what" and contemplates the human condition.

In this session, we will discuss with researchers from various fields how human consciousness and social aspects are changing, and discuss the not-so-fantastic future that can be found from super-fusion research.

Advance registration is required to attend the lecture, so please register as soon as possible.

Panel Discussion: Humanome Research, Beginning
Date: Friday, March 3, 16:20-17:40
Venue: Main Hall, 4F, TEPIA Advanced Technology Pavilion
Overview:
<Speakers
Mr. Takuji Yamada, Executive Vice President CTO, Metagen, Inc.
Mr. Ryu Nakagi, President and Representative Director, Rhelixa Corporation
Mr. Takanori Kobayashi, Representative Director, Neurospace Inc.
Dr. Masahiro Shinohara, Lecturer, Department of Systems Development and Regenerative Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University
<Organizer
Jyo Inoue, Executive Vice President CTO, Liverness, Inc.

Introduction of Speakers
Mr. Takuji Yamada
Executive Vice President CTO, Metagen, Inc.

D. in 2006 from the Graduate School of Science, Kyoto University. D. in Science. In 2015, he was appointed as Executive Vice President CTO of Metagen, Inc. He aims to elucidate the interaction between humans and intestinal bacteria through metabolites by compiling a database of metabolic pathways woven by bacterial communities living symbiotically in the human intestine.

Mr. Ryu Nakaki
President and Representative Director, Rhelixa Corporation

D. from the University of Tokyo. Computational biologist. He founded Rhelixa Inc. in February 2015.

Mr. Takanori Kobayashi
Representative Director, Neurospace Inc.

President, SleepTech Venture NeuroSpace, Inc. https://neurospace.jp/ In order to fundamentally solve sleep problems, he developed the "Corporate Sleep Improvement Program" in collaboration with universities and medical institutions. He has been a one-man sales force for 30 companies, mainly large corporations, and has improved the sleep of many employees at those companies. In addition, he is working to spread "sleep education" in schools and collaborating with many institutions to help students learn about sleep, which is an important wisdom for living. We aim to create a world where each individual can design and enjoy sleep, one of the three major needs, in the same way that people today enjoy a meal at a restaurant. Ideal sleeping hours: 7 hours and 30 minutes

Mr. Masahiro Shinohara
Lecturer, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University

D. in Agricultural Chemistry from the University of Tokyo and a Master's and Doctoral degree in Applied Biochemistry from the Graduate School of Agricultural and Life Sciences, the University of Tokyo. He was a postdoctoral fellow at the Institute for Molecular and Cellular Biology, The University of Tokyo, an assistant professor at the Graduate School of Medicine, Shinshu University, and an assistant professor at the Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University before assuming his current position. He is also a PRESTO researcher of the Japan Science and Technology Agency's Strategic Basic Research Program. He hopes to develop meaningful research to support a super-aging society.

Organizer Introduction
Joe Inoue
Leave a Nest Co., Ltd.
Executive Vice President CTO

Executive Vice President CTO, Liverness, Inc.
One of the founding members of REVANES, he established REVANES with only undergraduate and graduate students of science and engineering while he was a graduate student. After completing his doctoral studies, he worked as an assistant professor and lecturer at the Department of Biological Sciences, Faculty of Science, Kitasato University, and as an assistant professor at the Graduate School of Medicine, Kyoto University, before being appointed and concurrently serving as a specially appointed associate professor at Keio University on August 1, 2015. While conducting research and development, he is responsible for launching joint research projects with universities and research institutions and supporting the establishment of research institutes.

In addition to this discussion, we have prepared a number of cross-disciplinary programs over the two days, including cutting-edge research in academia, the latest startups, and advanced manufacturing initiatives in Japan. We are looking forward to your participation.

Applications for auditing (due February 28) are available on the conference website (see below).

Convention website:https://hic.lne.st/conference/kanto2018/

Apply for auditing:https://hic.lne.st/conference/kanto2018/#ticket

Contact us

Liverness Corporation (Attn: Nishiyama, Nakajima)

TEL：03-5227-4198 E-mail：[email protected]

Outline of the 7th Hyperdifferential Field Conference

What is the Hyper Interdisciplinary Conference?

Since 2002, when RIVERNESS was founded, we have held an annual "Super Hetero-Disciplinary Exchange Meeting" where students and researchers participating in internship programs at RIVERNESS discuss their thoughts on their research and issues they wish to solve through their research. Since 2012, the conference has evolved into a "super interdisciplinary conference" with the participation of researchers from industry and academia, where discussions are held from a broader perspective.

Today, the meeting is held annually as a gathering of people from diverse fields and industries, ranging from junior high and high school students, researchers and engineers in academia (including engineers from local factories), people involved in venture companies, accelerators, and managers and business development personnel from large corporations.